Rehabilitation of the chronic schizophrenic patient: psychopharmacological aspects.
作者信息
Kristjansen P, Fog R, Munkvad I
出版信息
Proc R Soc Med. 1976;69 suppl 1(Suppl 1):54-8. doi: 10.1177/00359157760690S114.
Abstract
摘要
相似文献
1
Rehabilitation of the chronic schizophrenic patient: psychopharmacological aspects.慢性精神分裂症患者的康复：精神药理学方面
Proc R Soc Med. 1976;69 suppl 1(Suppl 1):54-8. doi: 10.1177/00359157760690S114.
2
[Occurrence of tardive extrapyramidal symptoms in schizophrenic patients undergoing prolonged neuroleptic treatment].
Psychiatr Pol. 1979 Sep-Oct;13(5):479-85.
3
The cost of schizophrenia.精神分裂症的代价。
Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S65-9.
4
[Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].利培酮治疗慢性精神分裂症：与氟哌啶醇对比的多中心研究
Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1996 Jul-Aug;24(4):165-72.
5
New drugs for schizophrenia: an update for family physicians.治疗精神分裂症的新药：给家庭医生的最新资讯
Am Fam Physician. 1997 Sep 15;56(4):1149-56, 1159-60.
6
Kinematic analysis of handwriting movements in schizophrenic patients.精神分裂症患者书写动作的运动学分析
Biol Psychiatry. 1997 Apr 1;41(7):830-3. doi: 10.1016/S0006-3223(96)00544-6.
7
The long-term treatment of schizophrenia in the community.精神分裂症的社区长期治疗。
Practitioner. 1982 Jul;226(1369):1330-3.
8
[Long-term treatment and rehabilitation of schizophrenic patients].
Wien Klin Wochenschr Suppl. 1984;154:4-8.
9
[Neuroleptics in the prevention of schizophrenic relapse. Report of a meeting (author's transl)].[抗精神病药物在预防精神分裂症复发中的应用。会议报告（作者译）]
Nervenarzt. 1979 Nov;50(11):734-7.
10
Management of chronic schizophrenic outpatients.慢性精神分裂症门诊患者的管理
Psychiatr Clin North Am. 1986 Mar;9(1):143-51.
本文引用的文献
1
[STUDY ON THE PROBLEM OF DURATION OF THE DISEASE DURING THERAPY WITH PSYCHOPHARMACOLOGICAL AGENTS].[精神药物治疗期间疾病持续时间问题的研究]
Nervenarzt. 1964 Nov;35:488-91.
2
The long-term effect of perphenazine enanthate on the rat brain. Some metabolic and anatomical observations.庚酸奋乃静对大鼠脑的长期影响。一些代谢和解剖学观察。
Psychopharmacologia. 1973;29(4):329-36. doi: 10.1007/BF00429280.
3
Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates.精神分裂症患者后续护理中的药物治疗与社会心理治疗。一年复发率。
Arch Gen Psychiatry. 1973 Jan;28(1):54-64. doi: 10.1001/archpsyc.1973.01750310038007.
4
Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes.
Acta Neurol Scand. 1970;46(2):249-51. doi: 10.1111/j.1600-0404.1970.tb05621.x.
5
The main clinical classifications of neuroleptics.
Acta Psychiatr Belg. 1974 Sep;74(5):447-61.
6
The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.左旋多巴对使用抗精神病药物治疗的单纯型精神分裂症年轻患者的影响：美多芭与安慰剂的双盲交叉试验
Psychopharmacologia. 1975 Oct 14;44(1):105-10. doi: 10.1007/BF00421193.
Zotero 插件